LTFS
UTMD icon

Ladenburg Thalmann Financial Services’s Utah Medical Products UTMD Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$18K Buy
279
+78
+39% +$7.9K ﹤0.01% 4205
2019
Q3 		$19K Buy
+201
New +$18.7K ﹤0.01% 4081

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's UTMD Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Utah Medical Products (UTMD) stake by 39% in Q4 2019, buying an estimated $7.9K and bringing the position to 279 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4205.

Ladenburg Thalmann Financial Services first reported a position in UTMD in Q3 2019 and has held it in 2 quarters since. The position peaked at $19K in Q3 2019. 96 funds tracked by Wall St. Rank hold UTMD as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 279 shares of Utah Medical Products worth $18K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 78 Utah Medical Products shares in Q4 2019, an estimated $7.9K.
  • Utah Medical Products made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4205 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Utah Medical Products in Q3 2019 and has held it in 2 quarters since.
  • Ladenburg Thalmann Financial Services's Utah Medical Products position peaked at $19K in Q3 2019.
  • 96 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.